Año 2021
Hybrid 9th International Symposium of the European Working Groups of Myelodysplastic Syndromes (EWOG-MDS) and Severe Aplastic Anemia (SAA) in Children and Adolescents. Atenas (Grecia). 10 septiembre – 2 octubre, 2021
Clinical Characteristics, genomic landscape and functional studies of GATA2 deficiency in a cohort of Spanish patients
Damia Romero-Moya, Julio Castaño, Francesca De Giorgio, Francesca Lessi, Paolo Aretini, Chiara Maria Mazzanti, Loris Mularoni, Maximiliano Di Stefano, Alessandro Liquori, Jessica Gonzalez, Emilia J. Kozyra, Albert Catala?, Jose Carlos Rodriguez-Gallego, Josep Nomdedeu, Cristina Di?az de Heredia, Antonio Perez Martinez, Adela Escudero-Lopez, Fe?lix Lo?pez Cadenas, Mari?a Di?ez-Campelo, Teresa Gonza?lez, Carolina Marti?nez-Laperche, Nieves Dorado, Francisco Marco, Jose Cervera, Csaba Bödör, Marcin Wlodarski, Anna Bigas and Alessandra Giorgetti.
MDS Foundation 16th International Congress on MDS. Virtual. 23-26 septiembre,2021
Differencial clinical and mutational profile of Hypoplastic Myelodysplasic Syndromes
F. Hernandez Mohedo, Miguel Ángel Rodríguez Gil M. Bernal Sánchez, Lourdes Hermosín Ramos,Joaquín Sánchez García, María Vahí, Andrés Jerez, F. Solé Ristol, M. Bernal Sánchez, L. Palomo Sanchís, M. Expósito Ruiz, M. Jurado Chacón.
EHA 2021 Congress. Virtual. 9-17 junio, 2021
Myelodysplastic syndrome in young adult without previous organic disfunction: predominance of germline variants in genes of DNA repair pathway and their clinical impact.
Tzu-Hua Chen-Liang, Salvador Carrillo-Tornel, Ana María Hurtado, Marta Santiago, Esperanza Such, Laura Palomo, Miguel Ángel Rodriguez-Gil, María José Jimenez, Rafael del Orbe, Félix López-Cadenas, Mar Tormo, Lourdes Hermosín, Teresa Bernal, Eduardo Salido, Carmen Benet, Begoña Muiña, Raquel Oña, Nuria de Haro, Fernando Ramos, Francisco José Ortuño, Leonor Senent, Esperanza Tuset, Helena Pomares, Antonio Martínez-Francés, Teresa Arquero, Julia Montoro, Raúl Teruel-Montoya, José Cervera, David Valcárcel, Montserrat Arnán, Beatriz Arrizabalaga, María Diez-Campelo, Blanca Xicoy, Francisca Hernandez, Francesc Solé, Guillermo Sanz, Andrés Jerez.
ANALYSIS OF GERMLINE PREDISPOSITION IN PATIENTS WITH MYELOID NEOPLASMS: ASSOCIATION BETWEEN MOLECULAR ALTERATIONS AND CLINICAL HISTORY
Marta Santiago Balsera* , Alessandro Liquori, José Vicente Gil , Gayane Avetisyan, Lourdes Cordón, Beatriz Martín, Elvira Mora, Mariam Ibáñez, Claudia Sargas, Elisa González, Mireia Boluda, Mireya Morote, Cristian García, Cristina Martínez, Alejandra SanJuan, Marta Llop, Pau Montesinos, Eva Barragán, Miguel Ángel Sanz, Guillermo Sanz, Ángel Zúñiga, Esperanza Such, José Cervera»
Cohesin mutations are associated with a poor prognosis phenotype and a worse clinical outcome in low-risk myelodysplastic syndromes patients
Marta Martín Izquierdo; Félix López Cadenas; Javier Sánchez del Real; Alberto Hernández Sánchez; Jesús M Hernández Sánchez; Kamila Janusz; María Díez Campelo; Mar Tormo; Marta Megido; Carmen Olivier; Andrés Madinaveitia Ochoa; Julio Dávila; Magdalena Sierra; Manuel Vargas; Sandra Santos Mínguez; Cristina Miguel García; Rocío Benito; Jesús María Hernández Rivas; Fernando Ramos; María Abáigar.»
«Mesenchymal stromal cells as a potential therapeutic tool in enhancing residual healthy haematopoiesis in low-risk MDS patients
Tamara Jiménez Solas; Sandra Muntión Olave; Félix López Cadenas; Marta Martín Izquierdo; Teresa González Martínez; Kamila Janusz; Teresa Ezponda Itoiz; Alba Vilas Zomoza; Ana Alfonso Pierola; Felipe Prosper Cardoso; Antonieta Molero; David Valcárcel Ferreiras; Fermín Sánchez-Guijo Martín; María Díez Campelo.»
63rd ASH Annual Meeting and Exposition. Atlanta, Georgia (USA). 11-14 diciembre, 2021
Interobserver Variability with the Diagnosis of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) «» Is the Threshold of 20% Bone Marrow Blasts Reproducible?
Font, Patricia ; Loscertales , Javier; Muñoz Novas, Carolina; Lopez Rubio, Montserrat; Bermejo, Alfredo; Ricard, Pilar; Seri, Cristina; Soto, Carlos; Garcia Alonso, Luis; Piris Villaespesa, Miguel; Perez Segura, Gloria; Ballesteros, Monica; Benavente, Celina; Gomez Rojas, Sandra; Garcia Herce, Cristina; Castilla, Lucia; Cedena, Teresa; Ortuzar, Ariana; Jimenez Chillon, Carlos; Bellon Jose Maria; Villarubia, Jesus; Diez Martin, Jose Luis
«Uncovering perturbations in human hematopoiesis associated with healthy aging and myeloid malignancies at single cell resolution
Marina Ainciburu1,2*, Teresa Ezponda1,2*, Nerea Berastegui1, Ana Alfonso-Pierola2,3, Amaia Vilas-Zornoza1,2, Patxi San Martin-Uriz1,2, Diego Alignani4, Jose Lamo de Espinosa3 Mikel San Julian3, Tamara Jimenez5, F.lix L.pez5, Sandra Muntion5,9, Fermin Sanchez-Guijo5,9, Antonieta Molero6, Julia Montoro6, Guillermo Serrano8, Aintzane Diaz-Mazkiaran2,8, Miren Lasaga7, David Gomez-Cabrero7, Mar.a D.ez-Campelo5, David Valcarcel6, Mikel Hernaez8, Juan P. Romero1,2, §, Felipe Prosper1,2,3,9, §»
Treatment Patterns and Overall Survival in Patients with Intermediate-Risk Myelodysplastic Syndrome (MDS): A Retrospective Analysis in the Grupo Español de Síndromes Mielodisplásicos (GESMD) Spanish MDS Registry
María Díez-Campelo,1-3 Luis E. Benlloch,2 Emma Sasse,4 David Wormser,4 Leyla Hernandez Donoso,4 Silvia Colicino,4 Teresa Bernal,5 Antonieta Molero Yordi,6 Mar Tormo,2,7,8 Montserrat Arnan Sangerman,9 Guillermo Sanz,3,10 Marina Díaz-Beyá,11 María Teresa Cedena Romero,12 Andrés Jerez,13 Brayan Merchán,14 David Valcárcel Ferreiras2,5
Multiple TET2 Mutations as a New Biological Clue for Differentiating Oligomonocytic Chronic Mlomonocytic Leukemia from Myelodysplastic Syndromes.
Nieves Garcia-Gisbert1,2*, Leonor Arenillas, MD, PhD3,4*, David Roman-Bravo, MD3,5*, Juan José Rodríguez-Sevilla, MD5*, Brayan Merchan, MD2,5*, Sara Garcia-Avila, MD2,5*, Concepción Fernández-Rodríguez, PhD2,4*, Joan Gibert, PhD2*, Antonio Salar, MD, PhD2,5*, Beatriz Bellosillo, PhD1,2,4*, Ana Ferrer, MD, PhD3,4* and Xavier Calvo, MD, PhD3,4*
Non-Invasive Genetic Profiling and Monitoring in Myelodysplastic Syndromes
Nieves Garcia-Gisbert, Brayan Merchan, Sara Garcia-Avila, Marta Salido, Concepción Fernández-Rodríguez, Joan Gibert, Lierni Fernández-Ibarrondo, Laura Camacho, Marta Lafuente, Raquel Longarón, Blanca Espinet, Patricia Vélez, Marcio M Andrade-Campos, Ramon M. Pujol, Leonor Arenillas, Xavier Calvo, Carles Besses, Antonio Salar, Beatriz Bellosillos.
Clinical Outcomes of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) and Predictive Factors of Evolution of OM-CMML into Overt Chronic Myelomonocytic Leukemia (CMML)
16th International Congress on Myelodysplastic Syndromes. Toronto (Canadá) 23-26 septiembre, 2021
Predictive Factors of Oligomonocytic Chronic Myelomonocytic Leukemia (OM-CMML) Evolution to Overt Chronic Myelomonocytic Leukemia (CMML).